COVID-19: What's new in heme/onc
Dr. Alan P. Lyss examines how the COVID-19 pandemic has and will affect cancer care and research.
Surgical triage is necessary when resources are scarce.
Patients in gene therapy trials and those with factor inhibitors are of particular concern.
The American Society for Transplantation and Cellular Therapy document focuses on patient-treatment specifics and donor issues.
Expert advises diligence in screening cancer patients and commonsense preventative measures.